Synthesis, antitumor activity, molecular docking and DFT study of Novel pyrimidiopyrazole derivatives.
Clicks: 368
ID: 4032
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
78.7
/100
362 views
293 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In this investigation, the reaction of 2-cyano-N-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl) acetamide (3) with dimethylformamide dimethyl acetal (DMF-DMA) to afford the corresponding (E)-2-cyano-3-(dimethylamino)-N-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylamide (4) utilizing microwave irradiation. The condensation reactions of (E)-2-cyano-3-(dimethylamino)-N-(2,4-dioxo-1,2,3,4-tetrahydro pyrimidin-5-yl) acrylamide (4) with hydrazine derivatives to afford the equivalent pyrazole derivatives 6a and 6b; respectively. Selected of the synthesized compounds demonstrated outstanding in vitro antitumor activity against HepG2 cell line. Moreover, the evaluation of the greatest utilizing of molecular docking using Auto Dock tools for compound 1-phenyl-1H-pyrazole-5-carboxamide derivative 6b which interact with 4hdq synthase complex with interaction energy score (-4.5Kcal/mol) which is greater with short distance (1.727Å and 2.027Å). Also, the optimized molecular structure of the compounds, bond length, bond angles, energy gap HOMO-LUMO, IR frequencies were observed through DFT/ B3LYP/6+31G(d) which examine the equilibrium geometry of the new pyrazoles derivatives and the stability of HOMO/LUMO molecular orbitals.
| Reference Key |
fahim2019synthesiscurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Fahim, Asmaa M;Elshikh, Mohamed S;Darwish, Nora M; |
| Journal | current computer-aided drug design |
| Year | 2019 |
| DOI |
10.2174/1573409915666190710094425
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.